'One man, Professor Atul Butte director of the University of California Institute of Computational Health Sciences, believes that like other Silicon Valley startups, almost anyone can bring a drug to market from their garage with just a computer, the internet, and freely available data.'
As I've mentioned previously, sometimes a drug's side effect can provide another use for the drug, with the first approved purpose of the drug becoming a side effect of the newly intended use!
The genetic data from thousands of studies on humans, mice and other animals, that is now freely available, can be now be mined by computer programs to identify drugs which work for one condition and could potentially work for another condition.
David Glance, Director of UWA Centre for Software Practice, University of Western Australia, explains: theconversation.com/garage-...
We already have this situation with CLL, where a drug used to treat CLL has been repurposed for the much more lucrative Multiple Sclerosis market:
healthunlocked.com/cllsuppo...
Neil
Photo: Rainbow Lorikeet (parrot) in a flowering eucalyptus
Calling UK CLLers - Is government about to abandon support for protective monoclonal antibodies?
Ibrutinib. To take or not?
Astra Zeneca - no proof it causes blood clots
Starting Venetoclax mono on Monday
Ordered my Home PCR Test to access new treatments (Sotrovimab and Molnupiravir)
